Sunali Wadehra

Biologic therapies for psoriasis may have an impact on cardiovascular parameters, potentially resulting in the occurrence of major adverse cardiovascular events.

On subject questionnaire, 83.2% participants reported being “satisfied” or “very satisfied” with study treatment, and 90.2% subjects reported moderate symptomatic improvement.

These results demonstrate that the simultaneous application of radiofrequency and targeted pressure energy is a safe and effective treatment option for cellulite.

Pathologist characteristics, including level of experience and training, were analyzed in association with these assessments using multivariable logistic regression modeling.

Narrow-band ultraviolet B is a common therapy for vitiligo, and in nonsegmental vitiligo covering at least 20% of the body surface, it is the first-line treatment.

Treatment decisions are difficult to make in psoriasis patients, given the paucity of objective tools for evaluation of response to treatment.

Although this study is limited by its small sample size, the evidence suggests that oral sarecycline 1.5 mg/kg administered once daily may be a viable treatment option for moderate to severe acne.

Psoriasis is a chronic inflammatory systemic disease associated with several comorbid conditions, including chronic obstructive pulmonary disease and asthma.

Further communication between the patient and provider is needed to better understand the impact of disease severity and treatment.

Investigators analyzed data from the first year of VOYAGE 1, an ongoing, phase 3, double-blind, controlled trial of patients with moderate to severe psoriasis.